MDLN position history
The shares of Medline (MDLN) that Egerton Capital (UK) LLP reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2026 Q1: 4,365,802 shares, $194M, 2.2% of portfolio, New
- 2026 Q2: 16,470,884 shares, $650M, 6.3% of portfolio, Add +277.3%
- 2026 Q3: 13,283,017 shares, $461M, 4.7% of portfolio, Reduce −19.4%
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|